BlinkLab is trading 5.80% down at A$0.65, with no confirmed company-specific announcement explaining the move. - Shares gained 8.66% on September 30. - Available listings show prior ADHD study results from August, but these are not a clear explanation for the decline. - Supplied context points to broader healthcare-sector weakness amid rising Treasury yields, but does not establish a direct cause for BlinkLab’s move.